Our immunohistochemical results demonstrated that reduced NKD1 expression was associated with poor differentiation, high pTNM stage, lymph node metastasis and poor prognosis in NSCLC. Here, NKD1 is linked to metastatic malignant neoplasm in the lymph nodes.